Clinical approach to the diagnosis and successful management of anti-NMDA receptor encephalitis when antibody testing is not possible.

BMJ Case Rep

Department of Internal Medicine, North West Regional Health Authority, Port of Spain, Trinidad and Tobago.

Published: October 2019

Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a multistage illness that progresses from psychosis, memory deficits, seizures and language disintegration to a state of unresponsiveness with catatonic features often associated with abnormal movements, and autonomic and breathing instability. While the disorder predominantly affects children and young adults, and occurs with or without tumour association, the presence of a tumour (usually an ovarian teratoma) is dependent on the age, sex and ethnicity.Teratomas present more frequently in women older than 18 years, and are more predominant in black women than Caucasians. Here we present the case of a patient with probable anti-NMDA receptor encephalitis. She was subsequently found to have a mature teratoma of the ovary (dermoid cyst). Despite immune-modulated therapy, surgery was eventually performed to remove the cyst. This was met with a good clinical recovery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803151PMC
http://dx.doi.org/10.1136/bcr-2019-229593DOI Listing

Publication Analysis

Top Keywords

receptor encephalitis
12
anti-nmda receptor
8
clinical approach
4
approach diagnosis
4
diagnosis successful
4
successful management
4
management anti-nmda
4
encephalitis antibody
4
antibody testing
4
testing anti-n-methyl-d-aspartate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!